1: Antipsychotics in routine treatment are minor contributors to QT prolongation compared to genetics and age.

[Hommers Leif,Scherf-Clavel Maike,Stempel Roberta,Roth Julian,Falter Matthias,Deckert Jürgen,Mattheisen Manuel,Unterecker Stefan,Gawlik Micha]
J Psychopharmacol,2021 Mar 28;2698811211003477. PMID: 33779379

2: Haloperidol for preventing delirium in ICU patients: a systematic review and meta-analysis.

[Marra A,Vargas M,Buonanno P,Iacovazzo C,Kotfis K,Servillo G]
Eur Rev Med Pharmacol Sci,2021 Feb;25(3):1582-1591. PMID: 33629327

3: Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.

[Weibel Stephanie,Rücker Gerta,Eberhart Leopold Hj,Pace Nathan L,Hartl Hannah M,Jordan Olivia L,Mayer Debora,Riemer Manuel,Schaefer Maximilian S,Raj Diana,Backhaus Insa,Helf Antonia,Schlesinger Tobias,Kienbaum Peter,Kranke Peter]
Cochrane Database Syst Rev,2020 Oct 19;10:CD012859. PMID: 33075160

4: Intravenous haloperidol: A systematic review of side effects and recommendations for clinical use.

[Beach Scott R,Gross Anne F,Hartney Kimberly E,Taylor John B,Rundell James R]
Gen Hosp Psychiatry,Nov-Dec 2020;67:42-50. PMID: 32979582

5: Should we still monitor QTc duration in frail older patients on low-dose haloperidol? A prospective observational cohort study.

[Castro Ellen,Körver Frank,Merry Audrey,van Moorsel Fieke,Hazebroek Mark,Smid Machiel,Ploux Sylvain,Bordachar Pierre,Prinzen Frits,Sipers Walther,Strik Marc]
Age Ageing,2020 Aug 24;49(5):829-836. PMID: 32614955

6: QTc prolongation after haloperidol administration in critically ill patients post cardiovascular surgery: A cohort study and review of the literature.

[Burbuqe Ibrahimi,Boettger Soenke,Schubert Maria,Bettex Dominique,Rudiger Alain]
Palliat Support Care,2020 Aug;18(4):447-459. PMID: 32345400

7: Drug-specific risk of severe QT prolongation following acute drug overdose.

[Campleman Sharan L,Brent Jeffery,Pizon Anthony F,Shulman Joshua,Wax Paul,Manini Alex F,Toxicology Investigators’ Consortium (ToxIC)]
Clin Toxicol (Phila),2020 Dec;58(12):1326-1334. PMID: 32252558

8: Effect of Delirium on Physical Function in Noncardiac Thoracic Surgery Patients.

[Khan Sikandar H,Xu Chenjia,Wang Sophia,Gao Sujuan,Lasiter Sue,Kesler Kenneth,Khan Babar A]
Am J Crit Care,2020 Mar 1;29(2):e39-e43. PMID: 32114617

9: Efficacy and safety of haloperidol for delirium prevention in adult patients: An updated meta-analysis with trial sequential analysis of randomized controlled trials.

[Chen Zhen,Chen Rui,Zheng Donghua,Su Yongpeng,Wen Shuchao,Guo Huocheng,Ye Zhigang,Deng Yingxin,Liu Genglong,Zuo Liuer,Wei Xuxia,Hou Yunqi]
J Clin Anesth,2020 May;61:109623. PMID: 31672417

10: Sodium Valproate versus Continuous Infusion of Haloperidol in Management of Agitated Critically Ill Patients.

[Khalil Ramadan,Soliman Mohamed,Omer Mohamed,Aziz Kamel Abdel,Hussein Khaled]
Open Access Maced J Med Sci,2019 Aug 13;7(15):2440-2443. PMID: 31666843

11: Haloperidol for the treatment of delirium in critically ill patients: A systematic review with meta-analysis and Trial Sequential Analysis.

[Barbateskovic Marija,Krauss Sara R,Collet Marie O,Andersen-Ranberg Nina C,Mathiesen Ole,Jakobsen Janus C,Perner Anders,Wetterslev Jørn]
Acta Anaesthesiol Scand,2020 Feb;64(2):254-266. PMID: 31663112

12: QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia.

[Barreto Jason N,Cullen Michael W,Mara Kristin C,Grove Meagan E,Sierzchulski Amanda G,Dahl Nathan J,Tosh Pritish K,Dierkhising Ross A,Patnaik Mrinal M,Ackerman Michael J]
Leuk Lymphoma,2019 Dec;60(14):3512-3520. PMID: 31298598

13: Coprescription of QT interval-prolonging antipsychotics with potentially interacting medications in Thailand.

[Waleekhachonloet Onanong,Limwattananon Chulaporn,Rattanachotphanit Thananan]
Ther Adv Drug Saf,2019 Jun 13;10:2042098619854886. PMID: 31223470

14: Haloperidol for the management of delirium in adult intensive care unit patients: A systematic review and meta-analysis of randomized controlled trials.

[Zayed Yazan,Barbarawi Mahmoud,Kheiri Babikir,Banifadel Momen,Haykal Tarek,Chahine Adam,Rashdan Laith,Aburahma Ahmed,Bachuwa Ghassan,Seedahmed Elfateh]
J Crit Care,2019 Apr;50:280-286. PMID: 30665181

15: [ECG pearl: acquired long QT syndrome].

[Tomcsányi János,Tomcsányi Kristóf]
Orv Hetil,2018 Sep;159(39):1607-1610. PMID: 30543125

16: QTc Prolongation Associated With Psychiatric Medications: A Retrospective Cross-Sectional Study of Adult Inpatients.

[Shao Wanda,Ayub Shehzad,Drutel Robert,Heise William C,Gerkin Richard]
J Clin Psychopharmacol,Jan/Feb 2019;39(1):72-77. PMID: 30531476

17: Haloperidol affects coupling between QT and RR intervals in guinea pig isolated heart.

[Vesely Petr,Stracina Tibor,Hlavacova Miroslava,Halamek Josef,Kolarova Jana,Olejnickova Veronika,Mrkvicova Veronika,Paulova Hana,Novakova Marie]
J Pharmacol Sci,2019 Jan;139(1):23-28. PMID: 30528680

18: Low dose oral haloperidol does not prolong QTc interval in older acutely hospitalised adults: a subanalysis of a randomised double-blind placebo-controlled study.

[Schrijver Edmée Jm,Verstraaten Maaike,van de Ven Peter M,Bet Pierre M,van Strien Astrid M,de Cock Carel,Nanayakkara Prabath Wb]
J Geriatr Cardiol,2018 Jun;15(6):401-407. PMID: 30108611

19: Antipsychotics for treatment of delirium in hospitalised non-ICU patients.

[Burry Lisa,Mehta Sangeeta,Perreault Marc M,Luxenberg Jay S,Siddiqi Najma,Hutton Brian,Fergusson Dean A,Bell Chaim,Rose Louise]
Cochrane Database Syst Rev,2018 Jun 18;6(6):CD005594. PMID: 29920656

20: Drug-induced QT Interval Prolongation in the Intensive Care Unit.

[Etchegoyen Cecilia Villa,Keller Guillermo Alberto,Mrad Sebastian,Cheng Sixuan,Di Girolamo Guillermo]
Curr Clin Pharmacol,2017;12(4):210-222. PMID: 29473523

21: Evidence-Based Review Of Pharmacotherapy For Acute Agitation. Part 2: Safety.

[Zun Leslie S]
J Emerg Med,2018 Apr;54(4):522-532. PMID: 29433934

22: QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factors.

[Spellmann Ilja,Reinhard Matthias A,Veverka Diana,Zill Peter,Obermeier Michael,Dehning Sandra,Schennach Rebecca,Müller Norbert,Möller Hans-Jürgen,Riedel Michael,Musil Richard]
Eur Arch Psychiatry Clin Neurosci,2018 Jun;268(4):383-390. PMID: 29429138

23: {'#text': 'Validation and Clinical Utility of the hERG IC50:C Ratio to Determine the Risk of Drug-Induced Torsades de Pointes: A Meta-Analysis.', 'sub': 'max'}

[Lehmann David F,Eggleston William D,Wang Dongliang]
Pharmacotherapy,2018 Mar;38(3):341-348. PMID: 29380488

24: Comparison of Lurasidone Versus Quetiapine for the Treatment of Delirium in Critically Ill Patients.

[Fox Marlena A,Elefritz Jessica L,Huang Brandon M,Hunley Charles]
J Intensive Care Med,2020 Apr;35(4):394-399. PMID: 29357776

25: Comparison of haloperidol, non-haloperidol antipsychotics, and no pharmacotherapy for the management of delirium in an inpatient geriatric palliative care population.

[Felton Maria A,Jarrett Jennie B,Hoffmaster Richard,D'Amico Frank J,Sakely Heather,Pruskowski Jennifer]
J Pain Palliat Care Pharmacother,Jun-Sep 2018;32(2-3):141-148. PMID: 31066639

26: QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update.

[Beach Scott R,Celano Christopher M,Sugrue Alan M,Adams Caitlin,Ackerman Michael J,Noseworthy Peter A,Huffman Jeff C]
Psychosomatics,Mar-Apr 2018;59(2):105-122. PMID: 29275963

27: {'sub': '3', '#text': 'Haloperidol Versus 5-HT Receptor Antagonists for Postoperative Vomiting and QTc Prolongation: A Noninferiority Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.'}

[Singh Preet Mohinder,Borle Anuradha,Makkar Jeetinder Kaur,Trikha Anjan,Fish David,Sinha Ashish]
J Clin Pharmacol,2018 Feb;58(2):131-143. PMID: 28914976

28: Prevalence of QT interval prolonging drug-drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study.

[Khan Qasim,Ismail Mohammad,Haider Iqbal,Khan Fahadullah]
Int J Clin Pharm,2017 Dec;39(6):1256-1264. PMID: 28895028

29: BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats.

[Strinic Dean,Belosic Halle Zeljka,Luetic Kresimir,Nedic Ana,Petrovic Igor,Sucic Mario,Zivanovic Posilovic Gordana,Balenovic Dijana,Strbe Sanja,Udovicic Mario,Drmic Domagoj,Stupnisek Mirjana,Lovric Bencic Martina,Seiwerth Sven,Sikiric Predrag]
Life Sci,2017 Oct 1;186:66-79. PMID: 28797793

30: Influence of intravenous administration of the antipsychotic drug benperidol on the QT interval.

[Schmidt Alexander,Fischer Peter,Wally Beate,Scharfetter Joachim]
Neuropsychiatr,2017 Dec;31(4):172-175. PMID: 28791627

31: The anaesthetized rabbit with acute atrioventricular block provides a new model for detecting drug-induced Torsade de Pointes.

[Hagiwara Mihoko,Shibuta Seiji,Takada Kazuhiro,Kambayashi Ryuichi,Nakajo Misako,Aimoto Megumi,Nagasawa Yoshinobu,Takahara Akira]
Br J Pharmacol,2017 Aug;174(15):2591-2605. PMID: 28547743

32: Development of a risk score for QTc-prolongation: the RISQ-PATH study.

[Vandael Eline,Vandenberk Bert,Vandenberghe Joris,Spriet Isabel,Willems Rik,Foulon Veerle]
Int J Clin Pharm,2017 Apr;39(2):424-432. PMID: 28281228

33: Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study.

[Nosè M,Bighelli I,Castellazzi M,Martinotti G,Carrà G,Lucii C,Ostuzzi G,Sozzi F,Barbui C,STAR NETWORK GROUP]
Epidemiol Psychiatr Sci,2016 Dec;25(6):532-540. PMID: 26467074

34: The use of low-dose IV haloperidol is not associated with QTc prolongation: post hoc analysis of a randomized, placebo-controlled trial.

[Duprey Matthew S,Al-Qadheeb Nada,Roberts Russel,Skrobik Yoanna,Schumaker Greg,Devlin John W]
Intensive Care Med,2016 Nov;42(11):1818-1819. PMID: 27637718

35: Haloperidol Use Among Elderly Patients Undergoing Surgery: A Retrospective 1-Year Study in a Hospital Population.

[Nijboer Harmke,Lefeber Geert,McLullich Alidair,van Munster Barbara]
Drugs Real World Outcomes,2016 Mar;3(1):83-88. PMID: 27747805

36: Assessment of Safety Margin of an Antipsychotic Drug Haloperidol for Torsade de Pointes Using the Chronic Atrioventricular Block Dogs.

[Izumi-Nakaseko Hiroko,Nakamura Yuji,Cao Xin,Wada Takeshi,Ando Kentaro,Sugiyama Atsushi]
Cardiovasc Toxicol,2017 Jul;17(3):319-325. PMID: 27738880

37: Low proarrhythmic potential of citalopram and escitalopram in contrast to haloperidol in an experimental whole-heart model.

[Frommeyer Gerrit,Brücher Benedict,von der Ahe Henning,Kaese Sven,Dechering Dirk G,Kochhäuser Simon,Bogossian Harilaos,Milberg Peter,Eckardt Lars]
Eur J Pharmacol,2016 Oct 5;788:192-199. PMID: 27328775

38: Which QT Correction Formulae to Use for QT Monitoring?

[Vandenberk Bert,Vandael Eline,Robyns Tomas,Vandenberghe Joris,Garweg Christophe,Foulon Veerle,Ector Joris,Willems Rik]
J Am Heart Assoc,2016 Jun 17;5(6):e003264. PMID: 27317349

39: Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes.

[Zeng Haoyu,Roman Maria I,Lis Edward,Lagrutta Armando,Sannajust Frederick]
J Pharmacol Toxicol Methods,Sep-Oct 2016;81:217-22. PMID: 27222351

40: Specific prediction of clinical QT prolongation by kinetic image cytometry in human stem cell derived cardiomyocytes.

[Pfeiffer Emily R,Vega Raquel,McDonough Patrick M,Price Jeffrey H,Whittaker Ross]
J Pharmacol Toxicol Methods,Sep-Oct 2016;81:263-73. PMID: 27095424

41: Prescribing pattern of antipsychotic drugs during the years 1996-2010: a population-based database study in Europe with a focus on torsadogenic drugs.

[Oteri Alessandro,Mazzaglia Giampiero,Pecchioli Serena,Molokhia Mariam,Ulrichsen Sinna Pilgaard,Pedersen Lars,Poluzzi Elisabetta,De Ponti Fabrizio,Garbe Edeltraut,Schink Tania,Herings Ron,Bezemer Irene D,Sturkenboom Miriam C J M,Trifirò Gianluca]
Br J Clin Pharmacol,2016 Aug;82(2):487-97. PMID: 27061849

42: Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval.

[Barbui Corrado,Bighelli Irene,Carrà Giuseppe,Castellazzi Mariasole,Lucii Claudio,Martinotti Giovanni,Nosè Michela,Ostuzzi Giovanni,STAR NETWORK INVESTIGATORS]
PLoS One,2016 Feb 3;11(2):e0148212. PMID: 26840602

43: Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.

[Vandael Eline,Vandenberk Bert,Vandenberghe Joris,Spriet Isabel,Willems Rik,Foulon Veerle]
Int J Clin Pharm,2016 Apr;38(2):310-20. PMID: 26749342

44: Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice.

[Keller Guillermo A,Alvarez Paulino A,Ponte Marcelo L,Belloso Waldo H,Bagnes Claudia,Sparanochia Cecilia,Gonzalez Claudio D,Villa Etchegoyen M Cecilia,Diez Roberto A,Di Girolamo Guillermo]
Curr Drug Saf,2016;11(1):86-98. PMID: 26537523

45: The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project.

[Raschi Emanuel,Poluzzi Elisabetta,Salvo Francesco,Koci Ariola,Suling Marc,Antoniazzi Stefania,Perina Luisella,Hazell Lorna,Moretti Ugo,Sturkenboom Miriam,Garbe Edeltraut,Pariente Antoine,De Ponti Fabrizio]
Drug Saf,2016 Jan;39(1):59-68. PMID: 26446144

46: Intramuscular olanzapine for agitated patients: A systematic review and meta-analysis of randomized controlled trials.

[Kishi Taro,Matsunaga Shinji,Iwata Nakao]
J Psychiatr Res,2015 Sep;68:198-209. PMID: 26228420

47: A Randomized Controlled Trial of Intravenous Haloperidol vs. Intravenous Metoclopramide for Acute Migraine Therapy in the Emergency Department.

[Gaffigan Matthew E,Bruner David I,Wason Courtney,Pritchard Amy,Frumkin Kenneth]
J Emerg Med,2015 Sep;49(3):326-34. PMID: 26048068

48: Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol.

[Warnier Miriam Jacoba,Rutten Frans Hendrik,Souverein Patrick Cyriel,de Boer Anthonius,Hoes Arno Wilhelmus,De Bruin Marie Louise]
Pharmacoepidemiol Drug Saf,2015 Jul;24(7):701-8. PMID: 26013175

49: In-Hospital Haloperidol Use and Perioperative Changes in QTc-Duration.

[Blom M T,Jansen S,de Jonghe A,van Munster B C,de Boer A,de Rooij S E,Tan H L,van der Velde N]
J Nutr Health Aging,2015 May;19(5):583-9. PMID: 25923490

50: Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.

[Berling Ingrid,Isbister Geoffrey K]
Ann Emerg Med,2015 Aug;66(2):154-64. PMID: 25639523

51: An Evaluation of Adverse Drug Reactions Associated With Antipsychotic Use for the Treatment of Delirium in the Intensive Care Unit.

[Hale Genevieve M,Kane-Gill Sandra L,Groetzinger Lara,Smithburger Pamela L]
J Pharm Pract,2016 Aug;29(4):355-60. PMID: 25609664

52: Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.

[Kimura Goji,Kadoyama Kaori,Brown J B,Nakamura Tsutomu,Miki Ikuya,Nisiguchi Kohshi,Sakaeda Toshiyuki,Okuno Yasushi]
Int J Med Sci,2015 Jan 5;12(2):135-40. PMID: 25589889

53: QT Interval Prolongation Associated with Intramuscular Ziprasidone in Chinese Patients: A Case Report and a Comprehensive Literature Review with Meta-Analysis.

[Li Xian-Bin,Tang Yi-Lang,Zheng Wei,Wang Chuan-Yue,de Leon Jose]
Case Rep Psychiatry,2014;2014:489493. PMID: 25530900

54: Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials.

[Jensen Karsten Gjessing,Juul Klaus,Fink-Jensen Anders,Correll Christoph U,Pagsberg Anne Katrine]
J Am Acad Child Adolesc Psychiatry,2015 Jan;54(1):25-36. PMID: 25524787

55: QTc prolongation and haloperidol: just how risky is this drug?

[Howland Robert H]
Psychosomatics,Nov-Dec 2014;55(6):741-2. PMID: 25497511

56: Management of psychosis and agitation in medical-surgical patients who have or are at risk for prolonged QT interval.

[Ries Rose,Sayadipour Amirali]
J Psychiatr Pract,2014 Sep;20(5):338-44. PMID: 25226194

57: The comparative cardiac effects of haloperidol and quetiapine: parsing a review.

[Howland Robert H]
J Psychosoc Nurs Ment Health Serv,2014 Jun;52(6):23-6. PMID: 24967672

58: Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients.

[Tisdale James E,Jaynes Heather A,Kingery Joanna R,Overholser Brian R,Mourad Noha A,Trujillo Tate N,Kovacs Richard J]
Circ Cardiovasc Qual Outcomes,2014 May;7(3):381-90. PMID: 24803473

59: [Psychopharmalogical treatment of delirium in the elderly].

[Drach Lutz M]
Med Monatsschr Pharm,2014 Apr;37(4):124-31; quiz 133-4. PMID: 24779187

60: Aging effects on QT interval: Implications for cardiac safety of antipsychotic drugs.

[Rabkin Simon W]
J Geriatr Cardiol,2014 Mar;11(1):20-5. PMID: 24748877

61: Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.

[Kishi Taro,Matsuda Yuki,Iwata Nakao]
PLoS One,2014 Feb 4;9(2):e88049. PMID: 24505373

62: [QTc prolongation induced by intravenous sedation with Haloperidol, Prothipendyl and Lorazepam].

[Scharfetter Joachim,Fischer Peter]
Neuropsychiatr,2014;28(1):1-5. PMID: 24504742

63: Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial.

[Page Valerie J,Ely E Wesley,Gates Simon,Zhao Xiao Bei,Alce Timothy,Shintani Ayumi,Jackson Jim,Perkins Gavin D,McAuley Daniel F]
Lancet Respir Med,2013 Sep;1(7):515-23. PMID: 24461612

64: Comparison of droperidol and haloperidol for use by paramedics: assessment of safety and effectiveness.

[Macht Marlow,Mull Ashley C,McVaney Kevin E,Caruso Emily H,Johnston J Bill,Gaither Joshua B,Shupp Aaron M,Marquez Kevin D,Haukoos Jason S,Colwell Christopher B]
Prehosp Emerg Care,Jul-Sep 2014;18(3):375-80. PMID: 24460451

65: Drug-induced long QT in adult psychiatric inpatients: the 5-year cross-sectional ECG Screening Outcome in Psychiatry study.

[Girardin François R,Gex-Fabry Marianne,Berney Patricia,Shah Dipen,Gaspoz Jean-Michel,Dayer Pierre]
Am J Psychiatry,2013 Dec;170(12):1468-76. PMID: 24306340

66: Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe.

[Raschi Emanuel,Poluzzi Elisabetta,Godman Brian,Koci Ariola,Moretti Ugo,Kalaba Marija,Bennie Marion,Barbui Corrado,Wettermark Bjorn,Sturkenboom Miriam,De Ponti Fabrizio]
PLoS One,2013 Nov 20;8(11):e81208. PMID: 24278396

67: Safety profile of iloperidone in the treatment of schizophrenia.

[Dargani Navin V,Malhotra Anil K]
Expert Opin Drug Saf,2014 Feb;13(2):241-6. PMID: 24206391

68: Antipsychotics and the Risks of Sudden Cardiac Death and All-Cause Death: Cohort Studies in Medicaid and Dually-Eligible Medicaid-Medicare Beneficiaries of Five States.

[Leonard Charles E,Freeman Cristin P,Newcomb Craig W,Bilker Warren B,Kimmel Stephen E,Strom Brian L,Hennessy Sean]
J Clin Exp Cardiolog,2013;Suppl 10(6):1-9. PMID: 24027655

69: Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

[Leucht Stefan,Cipriani Andrea,Spineli Loukia,Mavridis Dimitris,Orey Deniz,Richter Franziska,Samara Myrto,Barbui Corrado,Engel Rolf R,Geddes John R,Kissling Werner,Stapf Marko Paul,Lässig Bettina,Salanti Georgia,Davis John M]
Lancet,2013 Sep 14;382(9896):951-62. PMID: 23810019

70: Optimisation of embryonic and larval ECG measurement in zebrafish for quantifying the effect of QT prolonging drugs.

[Dhillon Sundeep Singh,Dóró Eva,Magyary István,Egginton Stuart,Sík Attila,Müller Ferenc]
PLoS One,2013 Apr 8;8(4):e60552. PMID: 23579446

71: Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for torsade de pointes: a comparative, case-based evaluation.

[Fongemie Justin M,Al-Qadheeb Nada S,Estes N A Mark,Roberts Russel J,Temtanakitpaisan Yutthapong,Ruthazer Robin,Devlin John W]
Pharmacotherapy,2013 Jun;33(6):589-97. PMID: 23529904

72: Drug-drug interactions contributing to QT prolongation in cardiac intensive care units.

[Armahizer Michael J,Seybert Amy L,Smithburger Pamela L,Kane-Gill Sandra L]
J Crit Care,2013 Jun;28(3):243-9. PMID: 23312127

73: QTc prolongation, torsades de pointes, and psychotropic medications.

[Beach Scott R,Celano Christopher M,Noseworthy Peter A,Januzzi James L,Huffman Jeff C]
Psychosomatics,Jan-Feb 2013;54(1):1-13. PMID: 23295003

74: A computerized physician order entry set designed to improve safety of intravenous haloperidol utilization: a retrospective study in agitated hospitalized patients.

[Muzyk Andrew J,Rivelli Sarah K,Jiang Wei,Heinz Heather,Rayfield Amber,Gagliardi Jane P]
Drug Saf,2012 Sep 1;35(9):725-31. PMID: 22876752

75: Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.

[Muzyk Andrew J,Rayfield Amber,Revollo Jane Y,Heinz Heather,Gagliardi Jane P]
Drug Saf,2012 Jul 1;35(7):547-53. PMID: 22702639

76: Negative electro-mechanical windows are required for drug-induced Torsades de Pointes in the anesthetized guinea pig.

[Guns P-J,Johnson D M,Weltens E,Lissens J]
J Pharmacol Toxicol Methods,2012 Sep;66(2):125-34. PMID: 22516473

77: Improvement in QTc prolongation induced by zotepine following a switch to perospirone.

[Suzuki Yutaro,Watanabe Junzo,Sugai Takuro,Fukui Naoki,Ono Shin,Tsuneyama Nobuto,Saito Mami,Someya Toshiyuki]
Psychiatry Clin Neurosci,2012 Apr;66(3):244. PMID: 22443250

78: Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.

[Lee Hsin-Ya,Li Jih-Heng,Wu Li-Tzy,Wu Jin-Song,Yen Cheng-Fang,Tang Hsin-Pei]
Subst Abuse Treat Prev Policy,2012 Mar 20;7:11. PMID: 22429858

79: The electro-mechanical window in anaesthetized guinea pigs: a new marker in screening for Torsade de Pointes risk.

[Guns P-J,Johnson D M,Van Op den Bosch J,Weltens E,Lissens J]
Br J Pharmacol,2012 May;166(2):689-701. PMID: 22122450

80: QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes.

[Wenzel-Seifert Katharina,Wittmann Markus,Haen Ekkehard]
Dtsch Arztebl Int,2011 Oct;108(41):687-93. PMID: 22114630

81: Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up.

[Mönnig Gerold,Köbe Julia,Löher Andreas,Wasmer Kristina,Milberg Peter,Zellerhoff Stephan,Pott Christian,Zumhagen Sven,Radu Razvan,Scheld Hans H,Haverkamp Wilhelm,Schulze-Bahr Eric,Eckardt Lars]
Europace,2012 Mar;14(3):396-401. PMID: 21979994

82: Differential changes in QTc duration during in-hospital haloperidol use.

[Blom Marieke T,Bardai Abdennasser,van Munster Barbara C,Nieuwland Mei-Ing,de Jong Hendrik,van Hoeijen Daniel A,Spanjaart Anne M,de Boer Anthonius,de Rooij Sophia E,Tan Hanno L]
PLoS One,2011;6(9):e23728. PMID: 21961030

83: Safety of antipsychotics in the setting of QTc prolongation: the utility of the JT index.

[Mukherji Emily H,Bauer Leah K,Leskov Ilya,Januzzi James Louis,Tanev Kaloyan S]
Am J Psychiatry,2011 Sep;168(9):990-1. PMID: 21890808

84: Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case.

[Meyer-Massetti Carla,Vaerini Simone,Rätz Bravo Alexandra E,Meier Christoph R,Guglielmo B Joseph]
Int J Clin Pharm,2011 Oct;33(5):806-14. PMID: 21809143

85: Atypical antipsychotics for the treatment of ICU delirium.

[Gilchrist Neil A,Asoh Ifeoma,Greenberg Bruce]
J Intensive Care Med,Nov-Dec 2012;27(6):354-61. PMID: 21441282

86: Iloperidone for the treatment of schizophrenia.

[Bishop J R,Bishop D L]
Drugs Today (Barc),2010 Aug;46(8):567-79. PMID: 20830317

87: Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

[Cubeddu Luigi X]
Curr Cardiol Rev,2009 Aug;5(3):166-76. PMID: 20676275

88: Causes and management of drug-induced long QT syndrome.

[Ayad Ramy F,Assar Manish D,Simpson Leo,Garner John B,Schussler Jeffrey M]
Proc (Bayl Univ Med Cent),2010 Jul;23(3):250-5. PMID: 20671821

89: Effects of K openers on the QT prolongation induced by HERG-blocking drugs in guinea-pigs.

[Testai Lara,Cecchetti Violetta,Sabatini Stefano,Martelli Alma,Breschi Maria Cristina,Calderone Vincenzo]
J Pharm Pharmacol,2010 Jul;62(7):924-30. PMID: 20636881

90: Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.

[Miceli Jeffrey J,Tensfeldt Thomas G,Shiovitz Thomas,Anziano Richard J,O'Gorman Cedric,Harrigan Rachel H]
Clin Ther,2010 Mar;32(3):472-91. PMID: 20399985

91: The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?

[Meyer-Massetti Carla,Cheng Christine M,Sharpe Bradley A,Meier Christoph R,Guglielmo B Joseph]
J Hosp Med,2010 Apr;5(4):E8-16. PMID: 20394022

92: QT alterations in psychopharmacology: proven candidates and suspects.

[Alvarez Paulino Antonio,Pahissa Jaime]
Curr Drug Saf,2010 Jan;5(1):97-104. PMID: 20210726

93: Drug-induced QTc-interval prolongation in the intensive care unit: incidence and predictors.

[Ng Tien M H,Olsen Keith M,McCartan Megan A,Puumala Susan E,Speidel Katie M,Miller Melissa A,Sears Tom D]
J Pharm Pract,2010 Feb;23(1):19-24. PMID: 21507789

94: QTc prolongation and antipsychotic medications in a sample of 1017 patients with schizophrenia.

[Ozeki Yuji,Fujii Kumiko,Kurimoto Naoki,Yamada Naoto,Okawa Masako,Aoki Takesuke,Takahashi Jun,Ishida Nobuya,Horie Minoru,Kunugi Hiroshi]
Prog Neuropsychopharmacol Biol Psychiatry,2010 Mar 17;34(2):401-5. PMID: 20079791

95: Apparent desensitization of the effects of sigma receptor ligand haloperidol in isolated rat and guinea pig hearts after chronic treatment.

[Fialova Katerina,Krizanova Olga,Jarkovsky Jiri,Novakova Marie]
Can J Physiol Pharmacol,2009 Dec;87(12):1019-27. PMID: 20029538

96: Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.

[Vieweg W Victor R,Wood Mark A,Fernandez Antony,Beatty-Brooks Mary,Hasnain Mehrul,Pandurangi Anand K]
Drugs Aging,2009;26(12):997-1012. PMID: 19929028

97: Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.

[Devlin John W,Roberts Russel J,Fong Jeffrey J,Skrobik Yoanna,Riker Richard R,Hill Nicholas S,Robbins Tracey,Garpestad Erik]
Crit Care Med,2010 Feb;38(2):419-27. PMID: 19915454

98: Modulation of haloperidol induced electrophysiological alterations on cardiac action potential by various risk factors and gender difference.

[Raghu K G,Singh Richa,Prathapan A,Yadav Govind Kumar]
Chem Biol Interact,2009 Aug 14;180(3):454-9. PMID: 19433077

99: Torsade de pointes following intravenous haloperidol administration in a patient with complete heart block.

[Ginwalla Mahazarin,Biblo Lee Arnold,Paydak Hakan]
WMJ,2009 Feb;108(1):48-50. PMID: 19326637

100: Low-dose haloperidol-associated QTc prolongation.

[Stepkovitch Khatuna,Heagle Bahn Christine,Gupta Reeta]
J Am Geriatr Soc,2008 Oct;56(10):1963-4. PMID: 19054204

101: Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients.

[Freeman Bradley D,Dixon David J,Coopersmith Craig M,Zehnbauer Barbara A,Buchman Timothy G]
Pharmacoepidemiol Drug Saf,2008 Oct;17(10):971-81. PMID: 18693297

102: An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.

[Dhein Stefan,Perlitz Franziska,Mohr Friedrich-Wilhelm]
Naunyn Schmiedebergs Arch Pharmacol,2008 Dec;378(6):631-44. PMID: 18648775

103: Haloperidol plus ondansetron versus ondansetron alone for prophylaxis of postoperative nausea and vomiting.

[Grecu Loreta,Bittner Edward A,Kher Jay,Smith Sarah E,Rosow Carl E]
Anesth Analg,2008 May;106(5):1410-3, table of contents. PMID: 18420853

104: The prophylactic effect of haloperidol plus dexamethasone on postoperative nausea and vomiting in patients undergoing laparoscopically assisted vaginal hysterectomy.

[Chu Chin-Chen,Shieh Ja-Ping,Tzeng Jann-Inn,Chen Jen-Yin,Lee Yi,Ho Shung-Tai,Wang Jhi-Joung]
Anesth Analg,2008 May;106(5):1402-6, table of contents. PMID: 18420851

105: Asymptomatic QTc prolongation during coadministration of aripiprazole and haloperidol.

[Leo Roberto,Razzini Cinzia,Di Lorenzo Giorgio,Bianchi Francesco,Tesauro Manfredi,Zanasi Marco,Siracusano Alberto,Romeo Francesco]
J Clin Psychiatry,2008 Feb;69(2):327-8. PMID: 18363460

106: A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.

[Chaves A A,Zingaro G J,Yordy M A,Bustard K A,O'Sullivan S,Galijatovic-Idrizbegovic A,Schuck H,Christian D B,Hoe C M,Briscoe R J]
J Pharmacol Toxicol Methods,Sep-Oct 2007;56(2):103-14. PMID: 17643323

107: Comparison of guinea-pig ventricular myocytes and dog Purkinje fibres for in vitro assessment of drug-induced delayed repolarization.

[Terrar Derek A,Wilson C M,Graham S G,Bryant S M,Heath B M]
J Pharmacol Toxicol Methods,Sep-Oct 2007;56(2):171-85. PMID: 17596973

108: State dependent dissociation of HERG channel inhibitors.

[Stork D,Timin E N,Berjukow S,Huber C,Hohaus A,Auer M,Hering S]
Br J Pharmacol,2007 Aug;151(8):1368-76. PMID: 17592502

109: Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs.

[Kågström Jens,Sjögren Eva-Lena,Ericson Ann-Christin]
J Pharmacol Toxicol Methods,Sep-Oct 2007;56(2):186-93. PMID: 17582787

110: Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.

Prescrire Int,2007 Apr;16(88):59-62. PMID: 17458045

111: QT prolongation in guinea pigs for preliminary screening of torsadogenicity of drugs and drug-candidates. II.

[Testai L,Breschi M C,Martinotti E,Calderone V]
J Appl Toxicol,May-Jun 2007;27(3):270-5. PMID: 17265420

112: Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol.

[Tisdale James E,Kovacs Richard,Mi Deming,McCabe George P,Cariera Beth L,Sharma Nagaraja,Rosman Howard]
Pharmacotherapy,2007 Feb;27(2):175-82. PMID: 17253907

113: Sertindole: efficacy and safety in schizophrenia.

[Lindström Eva,Levander Sten]
Expert Opin Pharmacother,2006 Sep;7(13):1825-34. PMID: 16925508

114: Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjects.

[Park Ji-Young,Shon Ji-Hong,Kim Kyoung-Ah,Jung Hyun-Ju,Shim Joo-Cheol,Yoon Young-Ran,Cha In-June,Shin Jae-Gook]
J Clin Psychopharmacol,2006 Apr;26(2):135-42. PMID: 16633141

115: QT PRODACT: sensitivity and specificity of the canine telemetry assay for detecting drug-induced QT interval prolongation.

[Miyazaki Hiroyasu,Watanabe Hiroyuki,Kitayama Tetsuya,Nishida Masahiro,Nishi Yasuhiro,Sekiya Koji,Suganami Hideki,Yamamoto Keiji]
J Pharmacol Sci,2005;99(5):523-9. PMID: 16493192

116: QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation.

[Ando Kentaro,Hombo Toshiyasu,Kanno Akihiro,Ikeda Hironobu,Imaizumi Masakazu,Shimizu Noritsugu,Sakamoto Kengo,Kitani Shin-ichi,Yamamoto Yoshinori,Hizume Shingo,Nakai Keiko,Kitayama Tetsuya,Yamamoto Keiji]
J Pharmacol Sci,2005;99(5):487-500. PMID: 16493189

117: QT PRODACT: in vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals.

[Toyoshima Shigeki,Kanno Akihiro,Kitayama Tetsuya,Sekiya Koji,Nakai Keiko,Haruna Masao,Mino Terumasa,Miyazaki Hiroyasu,Yano Koji,Yamamoto Keiji]
J Pharmacol Sci,2005;99(5):459-71. PMID: 16493187

118: In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation.

[Milan David J,Jones Ian L,Ellinor Patrick T,MacRae Calum A]
Am J Physiol Heart Circ Physiol,2006 Jul;291(1):H269-73. PMID: 16489111

119: Assessment of drug-induced QT interval prolongation in conscious rabbits.

[Kijtawornrat A,Ozkanlar Y,Keene B W,Roche B M,Hamlin D M,Hamlin R L]
J Pharmacol Toxicol Methods,Mar-Apr 2006;53(2):168-73. PMID: 16290300

120: Aripiprazole: new drug. Just another neuroleptic.

Prescrire Int,2005 Oct;14(79):163-7. PMID: 16285069

121: Antipsychotic drugs and QT prolongation.

[Stöllberger Claudia,Huber Johannes O,Finsterer Josef]
Int Clin Psychopharmacol,2005 Sep;20(5):243-51. PMID: 16096514

122: A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.

[Greco K Elizabeth,Tune Larry E,Brown Frank W,Van Horn William A]
J Clin Psychiatry,2005 Jul;66(7):928-9. PMID: 16013910

123: Excellent review of psychotropic drug-induced torsade de pointes.

[Vieweg W V R]
Acta Psychiatr Scand,2005 Jul;112(1):78; author reply 78-9. PMID: 15952952

124: QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy.

[Sala Michela,Vicentini Alessandro,Brambilla Paolo,Montomoli Cristina,Jogia Jigar Rs,Caverzasi Eduardo,Bonzano Alberto,Piccinelli Marco,Barale Francesco,De Ferrari Gaetano M]
Ann Gen Psychiatry,2005 Jan 25;4(1):1. PMID: 15845138

125: Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors.

[Justo D,Prokhorov V,Heller K,Zeltser D]
Acta Psychiatr Scand,2005 Mar;111(3):171-6. PMID: 15701100

126: Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.

[Titier Karine,Girodet Pierre-Olivier,Verdoux Hélène,Molimard Mathieu,Bégaud Bernard,Haverkamp Wilhelm,Lader Malcolm,Moore Nicholas]
Drug Saf,2005;28(1):35-51. PMID: 15649104

127: Intramuscular haloperidol or lorazepam and QT intervals in schizophrenia.

[Harvey Anne T,Flockhart David,Gorski J Christopher,Greenblatt David J,Burke Michael,Werder Steve,Preskorn Sheldon H]
J Clin Pharmacol,2004 Oct;44(10):1173-84. PMID: 15342619

128: QT analysis: a complex answer to a 'simple' problem.

[Li Lang,Desai Mehul,Desta Zeruesenay,Flockhart David]
Stat Med,2004 Sep 15;23(17):2625-43. PMID: 15316947

129: Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice.

[Titier Karine,Canal Mireille,Déridet Evelyne,Abouelfath Abdelilah,Gromb Sophie,Molimard Mathieu,Moore Nicholas]
Toxicol Appl Pharmacol,2004 Aug 15;199(1):52-60. PMID: 15289090

130: QT prolongation in anaesthetized guinea-pigs: an experimental approach for preliminary screening of torsadogenicity of drugs and drug candidates.

[Testai L,Calderone V,Salvadori A,Breschi M C,Nieri P,Martinotti E]
J Appl Toxicol,May-Jun 2004;24(3):217-22. PMID: 15211616

131: Haloperidol in palliative care.

[Vella-Brincat Jane,Macleod A D]
Palliat Med,2004 Apr;18(3):195-201. PMID: 15198132

132: Prolonged cardiac repolarization after tacrolimus and haloperidol administration in the critically ill patient.

[Akers Wendell S,Flynn Jeremy D,Davis George A,Green Amy E,Winstead P Shane,Strobel Gunnar]
Pharmacotherapy,2004 Mar;24(3):404-8. PMID: 15040655

133: Dopamine partial agonists: a new class of antipsychotic.

[Lieberman Jeffrey A]
CNS Drugs,2004;18(4):251-67. PMID: 15015905

134: A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.

[Harrigan Edmund P,Miceli Jeffrey J,Anziano Richard,Watsky Eric,Reeves Karen R,Cutler Neal R,Sramek John,Shiovitz Thomas,Middle Michelle]
J Clin Psychopharmacol,2004 Feb;24(1):62-9. PMID: 14709949

135: QTc prolongation: possible association with risperidone and/or haloperidol.

[Nandagopal Jayasree J,Craig Jeffrey M,Lippmann Steven]
Psychosomatics,Nov-Dec 2003;44(6):521. PMID: 14597690

136: Torsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use.

[Hassaballa Hesham A,Balk Robert A]
Expert Opin Drug Saf,2003 Nov;2(6):543-7. PMID: 14585064

137: QTc prolongation due to propranolol overdose.

[Farhangi Vida,Sansone Randy A]
Int J Psychiatry Med,2003;33(2):201-2. PMID: 12968835

138: Antipsychotic drugs and QT interval prolongation.

[Zareba Wojciech,Lin David A]
Psychiatr Q,Fall 2003;74(3):291-306. PMID: 12918603

139: Variability of heart rate correction methods for the QT interval.

[Desai Mehul,Li Lang,Desta Zeruesenay,Malik Marek,Flockhart David]
Br J Clin Pharmacol,2003 Jun;55(6):511-7. PMID: 12814443

140: Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6.

[Desai M,Tanus-Santos J E,Li L,Gorski J C,Arefayene M,Liu Y,Desta Z,Flockhart D A]
Pharmacogenomics J,2003;3(2):105-13. PMID: 12746736

141: Ziprasidone in the management of schizophrenia : the QT interval issue in context.

[Taylor David]
CNS Drugs,2003;17(6):423-30. PMID: 12697001

142: Management of the violent patient.

[Brice Jane H,Pirrallo Ronald G,Racht Edward,Zachariah Brian S,Krohmer Jon]
Prehosp Emerg Care,Jan-Mar 2003;7(1):48-55. PMID: 12540143

143: Torsade de pointes associated with the administration of intravenous haloperidol.

[Hassaballa Hesham A,Balk Robert A]
Am J Ther,Jan-Feb 2003;10(1):58-60. PMID: 12522522

144: The effects of the FDA warning on the use of droperidol by u.s. Emergency physicians.

[Richards John R,Weiss Steven J,Bretz Stephen W,Schneir Aaron B,Rinetti Dauna,Derlet Robert W]
Cal J Emerg Med,2003 Jan;4(1):3-9. PMID: 20852711

145: Investigation of the potential of clozapine to cause torsade de pointes.

[Warner Barbara,Hoffmann Peter]
Adverse Drug React Toxicol Rev,2002;21(4):189-203. PMID: 12503253

146: Blinded test in isolated female rabbit heart reliably identifies action potential duration prolongation and proarrhythmic drugs: importance of triangulation, reverse use dependence, and instability.

[Hondeghem Luc M,Hoffmann Peter]
J Cardiovasc Pharmacol,2003 Jan;41(1):14-24. PMID: 12500017

147: Aripiprazole.

[McGavin Jane K,Goa Karen L]
CNS Drugs,2002;16(11):779-86; discussion 787-8. PMID: 12383035

148: Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death.

[Glassman A H,Bigger J T]
Am J Psychiatry,2001 Nov;158(11):1774-82. PMID: 11691681

149: Olanzapine: new preparation. Keep an eye on this neuroleptic.

Prescrire Int,1999 Oct;8(43):135-8. PMID: 11503836

150: The association between intravenous haloperidol and prolonged QT interval.

[Hatta K,Takahashi T,Nakamura H,Yamashiro H,Asukai N,Matsuzaki I,Yonezawa Y]
J Clin Psychopharmacol,2001 Jun;21(3):257-61. PMID: 11386487

151: Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part II: Pharmacological profile.

[Lande G,Demolombe S,Bammert A,Moorman A,Charpentier F,Escande D]
Cardiovasc Res,2001 May;50(2):328-34. PMID: 11334836

152: Analysis of the QTc interval during olanzapine treatment of patients with schizophrenia and related psychosis.

[Czekalla J,Beasley C M,Dellva M A,Berg P H,Grundy S]
J Clin Psychiatry,2001 Mar;62(3):191-8. PMID: 11305706

153: Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current.

[Witchel H J,Hancox J C]
Clin Exp Pharmacol Physiol,2000 Oct;27(10):753-66. PMID: 11022966

154: Drug interactions with cisapride: clinical implications.

[Michalets E L,Williams C R]
Clin Pharmacokinet,2000 Jul;39(1):49-75. PMID: 10926350

155: Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential.

[Satoh Y,Sugiyama A,Tamura K,Hashimoto K]
Jpn Circ J,2000 Jun;64(6):445-51. PMID: 10875735

156: Torsades de pointes secondary to intravenous haloperidol after coronary bypass grafting surgery.

[Perrault L P,Denault A Y,Carrier M,Cartier R,Bélisle S]
Can J Anaesth,2000 Mar;47(3):251-4. PMID: 10730737

157: Olanzapine. Keep an eye on this neuroleptic.

Can Fam Physician,2000 Feb;46:322-6, 330-6. PMID: 10690489

158: Haloperidol-induced torsade de pointes.

[O'Brien J M,Rockwood R P,Suh K I]
Ann Pharmacother,1999 Oct;33(10):1046-50. PMID: 10534216

159: The use of atypical antipsychotics in the management of schizophrenia.

[Campbell M,Young P I,Bateman D N,Smith J M,Thomas S H]
Br J Clin Pharmacol,1999 Jan;47(1):13-22. PMID: 10073734

160: Prolongation of QT interval in isolated feline hearts by antipsychotic drugs.

[Drici M D,Wang W X,Liu X K,Woosley R L,Flockhart D A]
J Clin Psychopharmacol,1998 Dec;18(6):477-81. PMID: 9864081

161: Torsade de pointes and low-dose oral haloperidol.

[Jackson T,Ditmanson L,Phibbs B]
Arch Intern Med,1997 Sep 22;157(17):2013-5. PMID: 9308514

162: The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.

[Suessbrich H,Schönherr R,Heinemann S H,Attali B,Lang F,Busch A E]
Br J Pharmacol,1997 Mar;120(5):968-74. PMID: 9138706

163: Significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change.

[Iwahashi K]
Clin Neuropharmacol,1996 Jun;19(3):267-70. PMID: 8726546

164: Use of haloperidol infusions to control delirium in critically ill adults.

[Seneff M G,Mathews R A]
Ann Pharmacother,Jul-Aug 1995;29(7-8):690-3. PMID: 8520081

165: Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance.

[Faigel D O,Metz D C,Kochman M L]
Am J Gastroenterol,1995 May;90(5):822-4. PMID: 7733096

166: Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients.

[Di Salvo T G,O'Gara P T]
Clin Cardiol,1995 May;18(5):285-90. PMID: 7628136

167: Torsade de pointes associated with the use of intravenous haloperidol.

[Wilt J L,Minnema A M,Johnson R F,Rosenblum A M]
Ann Intern Med,1993 Sep 1;119(5):391-4. PMID: 8338292

168: Life-threatening ventricular arrhythmia (torsades de pointes) after haloperidol overdose.

[Henderson R A,Lane S,Henry J A]
Hum Exp Toxicol,1991 Jan;10(1):59-62. PMID: 1673626